TAIPEI, Taiwan – July 9, 2025 – THC Therapeutics, Inc. (THCT) announced today the strategic acquisition of SugarTop Buddery, a prominent craft cannabis brand based in Eugene, Oregon. The deal, valued at approximately $3 million, was structured as an all-share transaction, involving the issuance of newly created Series D Preferred stock by THC Therapeutics to acquire all outstanding membership interests of STHoldings Group LLC, the parent company of SugarTop Buddery.
This move marks the second significant purchase for THCT as it actively pursues a targeted “roll-up” strategy aimed at consolidating and expanding its presence within the burgeoning cannabis market. The acquisition follows closely on the heels of THC Therapeutics’ prior strategic purchase of The Headquarters Group in June 2025, underscoring the company’s aggressive inorganic growth trajectory.
Profile of SugarTop Buddery
Founded in 2015, SugarTop Buddery is celebrating its 10th anniversary this year. It has established itself in the Pacific Northwest cannabis landscape as a community-driven, music-inspired craft cannabis company. Known for its unique brand identity and connection to the arts, the company has gained recognition for its music and artist collaborations, popular pre-rolls, and a notable focus on social equity and supporting women in the cannabis industry.
Located in Eugene, Oregon, SugarTop Buddery has cultivated a loyal customer base and a distinct brand ethos rooted in its local community and passion points.
Strategic Rationale and Future Outlook
The acquisition is poised to significantly impact SugarTop Buddery’s future growth trajectory. According to Anna Kaplan, co-founder and CEO of SugarTop Buddery, joining THC Therapeutics provides essential resources necessary for scaling the brand.
Ms. Kaplan stated, “Becoming part of THC Therapeutics will furnish us with the capital, infrastructure, and resources needed for the SugarTop Buddery brand to expand not only nationally but also internationally.” This perspective highlights the strategic benefit for smaller, established brands like SugarTop Buddery to leverage the resources of a larger entity like THCT for broader market penetration.
THC Therapeutics’ roll-up strategy typically involves acquiring multiple smaller companies within an industry to consolidate market share, achieve economies of scale, and enhance operational efficiencies. By integrating brands such as SugarTop Buddery and The Headquarters Group, THCT aims to build a larger, more diversified portfolio capable of competing on a national and potentially international stage.
Market Implications
The cannabis industry continues to see consolidation and strategic mergers as companies seek to navigate varying regulatory landscapes and capture market share. THCT’s latest acquisition underscores the ongoing trend of larger firms absorbing craft or regionally popular brands to expand their geographic reach and product offerings.
The all-share transaction method, utilizing newly created Series D Preferred stock, reflects a common approach in growth-focused industries where companies leverage equity to fund expansion without significant cash outlay. This structure allows THCT to preserve capital while bringing SugarTop Buddery’s brand equity, operational capabilities, and market presence under its corporate umbrella.
For SugarTop Buddery, the acquisition represents a pivotal moment, transitioning from a decade as an independent craft producer to becoming part of a larger, expanding enterprise. The stated goal of national and international expansion signals THC Therapeutics’ ambition for the brand, potentially introducing its unique music-inspired and community-focused identity to new markets.
This acquisition, announced on July 9, 2025, positions THC Therapeutics for further expansion as it integrates SugarTop Buddery into its operations and continues to execute its strategic roll-up plan in the dynamic cannabis sector.
